526445
INDRANIB
Start SIP
Invest Now
Start SIP in INDRANIB
Performance
- Low
- ₹8
- High
- ₹9
- 52 Week Low
- ₹8
- 52 Week High
- ₹26
- Open Price₹9
- Previous Close₹9
- Volume15,894
- 50 DMA₹10.71
- 100 DMA₹12.10
- 200 DMA₹15.53
Investment Returns
- Over 1 Month -12.37%
- Over 3 Month -43.6%
- Over 6 Month -33.23%
- Over 1 Year -64.66%
Smart Investing Starts Here Start SIP with Indrayani Biotech for Steady Growth!
Indrayani Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -5.1
- PEG Ratio
- 0
- Market Cap Cr
- 39
- P/B Ratio
- 0.5
- Average True Range
- 0.78
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.75
- RSI
- 33.87
- MFI
- 28.4
Indrayani Biotech Financials
Indrayani Biotech Technicals
EMA & SMA
Current Price
₹8.50
0
(0%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹9.35
- 50 Day
- ₹10.71
- 100 Day
- ₹12.10
- 200 Day
- ₹15.53
Resistance and Support
8.63
- R3 9.45
- R2 9.22
- R1 8.86
- S1 8.27
- S2 8.04
- S3 7.68
Indrayani Biotech Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-12-11 | Quarterly Results | |
| 2025-08-30 | Others | Inter-alia, to consider 1. Notice of the 33rd AGM of the Company. 2. Appointment of Mr. Swaminathan & Mr. Singarababu Indirakumar as Whole-Time Director. 3. Other business matters. |
| 2025-08-14 | Quarterly Results | |
| 2025-06-12 | Audited Results | (Revised) |
| 2025-04-03 | Rights issue of Equity Shares |
Indrayani Biotech F&O
About Indrayani Biotech
- NSE Symbol
- INDRANIB
- BSE Symbol
- 526445
- Managing Director
- Mr. Kasiraman Sayee Sundar
- ISIN
- INE007C01021
Similar Stocks to Indrayani Biotech
Indrayani Biotech FAQs
Indrayani Biotech share price is ₹8 As on 13 February, 2026 | 15:23
The Market Cap of Indrayani Biotech is ₹38.7 Cr As on 13 February, 2026 | 15:23
The P/E ratio of Indrayani Biotech is -5.1 As on 13 February, 2026 | 15:23
The PB ratio of Indrayani Biotech is 0.5 As on 13 February, 2026 | 15:23
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.